What I want patients and clinicians to take away from this is that if you or your patient has obesity, established cardiovascular disease, type 2 diabetes, CKD, HFpEF, MASH, or sleep apnea, this drug class should be a serious part of the treatment conversation
GLP-1s and Your Stomach: The Challenge The peptide nature of this hormone is why developing effective oral versions of GLP-1 medications has been so challenging, says Dr
Data shows that up to two-thirds of lost weight is regained within one year of discontinuation, which pushes many users toward extended or indefinite therapy
Kerlikowske K, Zhu W, Tosteson ANA, et al
Learn more in our comparison of Zealthy vs Hers vs Josie for weight loss
Understanding GLP-1s and their dynamic marketplace and workplace trends [Unpublished] With the availability of newer treatment options for weight management glucagon-like peptide 1 (GLP-1) medications metabolic health is in the news, shining a light for the public on the impact of weight on overall health
